Skip to main content
. 2014 Nov 2;2014:954045. doi: 10.1155/2014/954045

Figure 2.

Figure 2

Comparison of serum TAS levels of patients with metabolic syndrome and the control group (1.4 ± 0.4 μmol Trolox equivalent/L and 1.0 ± 0.2 μmol Trolox equivalent/L, resp.; P < 0.001).